desloratadine: Clinical Trials

77 trials of desloratadine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

62 completed, 5 not yet recruiting, 4 unknown, 3 recruiting. 27 Phase 4, 26 Phase 3, 10 Phase 2, 6 Phase 1, 5 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 427Completed 25, Terminated 1, Unknown 1
Phase 326Completed 21, Not yet recruiting 3, Terminated 1, Unknown 1
Phase 210Completed 4, Recruiting 3, Not yet recruiting 2, Unknown 1
Phase 16Completed 6
Not applicable5Completed 3, Suspended 1, Unknown 1

Follow desloratadine: new trials by email Literature Review of desloratadine trials Research Report on desloratadine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years
DEP114, Desloratadine - Persistent Allergic Rhinitis
Phase 3Not yet recruitingEMS3162027-06-012026-09-22
Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patients With Endometriosis
Desloratadine, Placebo - Endometriosis, Endometriosis (Diagnosis)
Phase 2Not yet recruitingMedical University of Vienna602027-02-012026-09-18
Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer
Biospecimen Collection, Cholecalciferol, Computed Tomography - Advanced Hepatocellular Carcinoma, Advanced Melanoma
Phase 2Not yet recruitingUniversity of Southern California462026-11-012026-09-23
Desloratadine as Adjunct Therapy for Rheumatoid Arthritis
Desloratadine 5 mg, Placebo - Rheumatoid Arthritis (RA), Rheumatoid Arthritis
Phase 2RecruitingHorus University602026-05-232026-06-08
Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients.
Autologous whole blood therapy, Desloratadine - Chronic Idiopathic Urticaria
Phase 3Not yet recruitingCairo University402026-04-302026-03-20
Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis
Roflumilast, Desloratadine, Placebo - Rheumatoid Arthritis
Phase 2RecruitingHorus University902026-04-232026-05-12
Desloratadine in Patients With Ulcerative Colitis
Desloratadine, mesalamine - Ulcerative Colitis (UC), Ulcerative Colitis
Phase 2RecruitingTanta University442026-01-262026-01-29
Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.
DEP114, Desloratadine 0.5 MG/ML - Allergic Rhinitis
Phase 3Not yet recruitingEMS3182025-02-152024-02-22
Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine
Desloratadine / Betamethasone in fixed dose, Desloratadine - Allergic Rhinitis
Phase 3CompletedLaboratorios Silanes S.A. de C.V.702024-11-112026-07-23
Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children
Desloratadine , Prednisolone, Desloratadine - Allergic Rhinitis
Phase 3CompletedEurofarma Laboratorios S.A.2622024-07-082026-10-26
Over-the-Counter Antihistamines & Heat Stress
50 mg Diphenhydramine, 10 mg Loratadine, 5 mg Desloratadine - Heat Illness, Allergic Rhinitis
Phase 4UnknownLakehead University162023-12-052024-01-22
Role of Desloratadine in Reducing Inflammation From Occupational Heat Strain
Desloratadine, Placebo, No Intervention - Heat Stress, Exertional, Inflammatory Response
Not applicableUnknownUniversity of Victoria122022-07-012022-07-06
Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.
Desloratadine Single Dose, Levocetirizine Single Dose, Desloratadine Fourfold Dose - Pruritus
Not applicableCompletedUniversitaire Ziekenhuizen KU Leuven122019-10-282020-05-27
Influence of Antipruritics on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.
Desloratadine 5 mg, Aprepitant 125 mg, Ketotifen 1 MG - Pruritus
Not applicableCompletedUniversitaire Ziekenhuizen KU Leuven132019-06-112020-05-27
Antiplatelet Therapy in Chronic Urticaria
Desloratadine plus cilostazol and dipyridamole, Desloratadine - Chronic Urticaria
Phase 2UnknownChulalongkorn University122018-06-012024-02-21
Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment
Aprepitant, Desloratadine, Placebo of aprepitant - Non-small Cell Lung Cancer
Phase 2CompletedSun Yat-sen University1382015-12-012021-05-18
Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Desloratadine 5 mg, Placebo - Seasonal Allergic Rhinitis
Phase 3CompletedOrganon and Co4492015-01-092024-05-17
Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment
Desloratadine + Prednisolone, Dexchlorpheniramine + Betamethasone - Cutaneous Hypersensitivity
Phase 3TerminatedEMS172014-02-012017-02-16
Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment
Dexchlorpheniramine + Betamethasone, Desloratadine + Prednisolone - Allergic Rhinitis
Phase 3CompletedEMS2102013-11-012015-01-15
Anti-histamines and Methacholine Challenges.
Diphenhydramine, cetirizine, desloratadine - Asthma
Phase 4CompletedDon Cockcroft122013-11-012015-04-08

Showing 20 of 77. Sign in to see all of them.

Conditions studied

Rhinitis, Allergic, Seasonal (17)  ·  Rhinitis, Allergic (13)  ·  Urticaria (13)  ·  Chronic Urticaria (7)  ·  Hypersensitivity (7)  ·  Rhinitis (7)  ·  Rhinitis, Allergic, Perennial (6)  ·  Asthma (4)  ·  Immune System Diseases (3)  ·  Pruritus (3)  ·  Arthritis, Rheumatoid (2)  ·  Dermatitis, Atopic (2)  ·  Heat Stress Disorders (2)  ·  Hypersensitivity, Immediate (2)  ·  Rhinorrhea (2)

Sponsors

Organon and Co (38)  ·  Dr. Reddy's Laboratories Limited (6)  ·  EMS (5)  ·  ALK-Abelló A/S (2)  ·  Charite University, Berlin, Germany (2)  ·  Horus University (2)  ·  Universitaire Ziekenhuizen KU Leuven (2)  ·  Cairo University (1)  ·  Chulalongkorn University (1)  ·  Don Cockcroft (1)  ·  Eurofarma Laboratorios S.A. (1)  ·  Faes Farma, S.A. (1)  ·  Grupo de Alergología Clínica y Experimental (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Iuliu Hatieganu University of Medicine and Pharmacy (1)

Countries

Canada (7)  ·  United States (6)  ·  Germany (5)  ·  Egypt (4)  ·  Belgium (3)  ·  Brazil (3)  ·  Spain (2)  ·  Austria (1)  ·  China (1)  ·  Colombia (1)  ·  France (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Mexico (1)  ·  Romania (1)

Top investigators

Antonio R Pizarro, MD (3)  ·  Antonio R. Pizarro, M.D., (2)  ·  Marcus Maurer, MD (2)  ·  Amira Mashaly (1)  ·  Diana Hanna (1)  ·  Donald W Cockcroft, MD (1)  ·  Donald W Cockcroft, MD, FRCP(C) (1)  ·  Dr.Denis Audet, MD (1)  ·  Jettanong Klaewsongkram, MD (1)  ·  Li Zhang, professor (1)

Results publications

PMID 15679739, PMID 16014882, PMID 16913264, PMID 16918326, PMID 17085262, PMID 17298105, PMID 17522250, PMID 17535226, PMID 18048820, PMID 18181978, PMID 19132976, PMID 19133920, PMID 19164343, PMID 19302250, PMID 19624554, PMID 19692680, PMID 19788025, PMID 19793151, PMID 20067329, PMID 20493771, PMID 20532044, PMID 20544226, PMID 20559006, PMID 20820812, PMID 21039410, PMID 21630130, PMID 21783417, PMID 22512843, PMID 22850916, PMID 22870909, PMID 22995650, PMID 23053062, PMID 23282979, PMID 23676577, PMID 24517320, PMID 26740893, PMID 26867531, PMID 27326985, PMID 28709817, PMID 36197287

NIH funding

2008 (1), P30CA014089 (1)